About InfuSystem (NYSEAMERICAN:INFU)
InfuSystem Holdings, Inc. is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics for the treatment of a range of cancers, including colorectal cancer, pain management and other disease states. It sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers and others.
Industry, Sector and Symbol
Industry Medical Equipment, Supplies & Distribution
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-1.06%
Return on Assets-0.59%
InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions
What is InfuSystem's stock symbol?
InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."
How were InfuSystem's earnings last quarter?
InfuSystem Holdings Inc (NYSEAMERICAN:INFU) posted its quarterly earnings data on Monday, December, 12th. The medical instruments supplier reported $0.00 EPS for the quarter. The medical instruments supplier had revenue of $17.23 million for the quarter. InfuSystem had a negative return on equity of 1.06% and a negative net margin of 0.73%. View InfuSystem's Earnings History.
Who are some of InfuSystem's key competitors?
Some companies that are related to InfuSystem include Bioquell (BQE), Tandem Diabetes Care (TNDM), Surgical Innovations Group (SUN), Capnia (SLNO), Alliqua Biomedical (ALQA), Cytori Therapeutics (CYTX), Lombard Medical (EVARF), NeuroMetrix (NURO), Great Basin Scientific (GBSN), InspireMD (NSPR), Asante Solutions (PUMP), LDR (LDRH) and Symmetry Medical (SMA).
Who are InfuSystem's key executives?
InfuSystem's management team includes the folowing people:
- Gregg O. Lehman Ph.D., Executive Chairman of the Board (Age 67)
- Richard A. Diiorio, President, Chief Executive Officer, Director (Age 43)
- Christopher Downs, Interim Chief Financial Officer, Executive Vice President (Age 59)
- Janet Skonieczny, Chief Operating Officer, Executive Vice President, Compliance Officer and Privacy Officer (Age 56)
- Trent N Smith, Executive Vice President, Chief Accounting Officer, Corporate Controller (Age 48)
- Michael Milton McReynolds, Executive Vice President, Chief Information Officer (Age 46)
- Darrell B. Montgomery, Director (Age 55)
- Ryan J. Morris, Director (Age 32)
- Christopher R. Sansone, Director
- Scott A. Shuda, Director (Age 50)
How do I buy InfuSystem stock?
Shares of InfuSystem can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is InfuSystem's stock price today?
One share of InfuSystem stock can currently be purchased for approximately $2.35.
How big of a company is InfuSystem?
InfuSystem has a market capitalization of $52.81 million.
How can I contact InfuSystem?
InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.
MarketBeat Community Rating for InfuSystem (INFU)MarketBeat's community ratings are surveys of what our community members think about InfuSystem and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
InfuSystem (NYSEAMERICAN:INFU) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
InfuSystem (NYSEAMERICAN:INFU) Earnings History and Estimates Chart
InfuSystem (NYSEAMERICAN INFU) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/9/2017||Q2 2017||($0.02)||$16.94 million||View||Listen|
|3/22/2017||Q4 2016||$0.07||($0.01)||$16.85 million||View||N/A|
|12/12/2016||Q3 2016||$0.00||$17.23 million||View||N/A|
|8/10/2016||Q216||$0.04||$17.20 million||$19.10 million||View||Listen|
|5/10/2016||Q116||$0.02||$16.70 million||$19.00 million||View||N/A|
|5/12/2015||Q115||$0.06||$0.03||$17.20 million||$16.70 million||View||Listen|
|3/9/2015||Q414||$0.05||$0.05||$17.20 million||$16.20 million||View||N/A|
|11/10/2014||Q3 2014||$0.05||$0.04||$16.61 million||View||N/A|
|8/1/2014||Q2 2014||$0.04||$16.37 million||View||N/A|
|5/5/2014||Q1 2014||$0.03||$0.03||$17.24 million||View||N/A|
InfuSystem (NYSEAMERICAN:INFU) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for InfuSystem (NYSEAMERICAN:INFU)
No dividend announcements for this company have been tracked by MarketBeat.com
InfuSystem (NYSEAMERICAN INFU) Insider Trading and Institutional Ownership History
InfuSystem (NYSEAMERICAN INFU) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|12/8/2017||Meridian Ohc Partners, Lp||Director||Buy||1,800||$2.30||$4,140.00|| |
|12/6/2017||Meridian Ohc Partners, Lp||Director||Buy||7,300||$2.30||$16,790.00|| |
|11/27/2017||Christopher R Sansone||Director||Buy||2,000||$2.20||$4,400.00|| |
|11/21/2017||Christopher R Sansone||Director||Buy||54,344||$2.09||$113,578.96|| |
|9/11/2017||Meridian Ohc Partners, Lp||Director||Buy||19,982||$2.00||$39,964.00|| |
|8/30/2017||Meridian Ohc Partners, Lp||Director||Buy||30,900||$1.90||$58,710.00|| |
|8/28/2017||Meridian Ohc Partners, Lp||Director||Buy||30,000||$1.90||$57,000.00|| |
|8/25/2017||Meridian Ohc Partners, Lp||Director||Buy||13,381||$1.84||$24,621.04|| |
|8/24/2017||Meridian Ohc Partners, Lp||Director||Buy||155||$1.80||$279.00|| |
|8/23/2017||Meridian Ohc Partners, Lp||Director||Buy||2,166||$1.80||$3,898.80|| |
|8/16/2017||Meridian Ohc Partners, Lp||Director||Buy||56,670||$1.84||$104,272.80|| |
|8/15/2017||Richard Dilorio||Director||Buy||4,875||$1.95||$9,506.25|| |
|8/14/2017||Christopher Downs||CFO||Buy||7,900||$1.90||$15,010.00|| |
|8/14/2017||Darrell B Montgomery||Director||Buy||25,000||$1.88||$47,000.00|| |
|6/7/2017||Meridian Ohc Partners, Lp||Director||Buy||10,109||$1.55||$15,668.95|| |
|6/2/2017||Meridian Ohc Partners, Lp||Director||Buy||10,100||$1.55||$15,655.00|| |
|5/25/2017||Meridian Ohc Partners, Lp||Director||Buy||6,105||$1.55||$9,462.75|| |
|5/19/2017||Ryan J Morris||Director||Buy||15,000||$1.28||$19,200.00|| |
|5/17/2017||Ryan J Morris||Director||Buy||29,614||$1.45||$42,940.30|| |
|3/27/2017||Ryan J Morris||Director||Buy||21,651||$2.20||$47,632.20|| |
|3/24/2017||Ryan J Morris||Director||Buy||94,200||$2.14||$201,588.00|| |
|12/19/2016||Eric K. Steen||Insider||Buy||12,000||$2.33||$27,960.00|| |
|12/16/2016||Meridian Ohc Partners, Lp||Director||Buy||200,000||$2.34||$468,000.00|| |
|9/14/2016||Ryan J Morris||Director||Buy||23,171||$2.85||$66,037.35|| |
|9/13/2016||Ryan J Morris||Director||Buy||16,829||$2.88||$48,467.52|| |
|9/8/2016||Ryan J Morris||Director||Buy||17,171||$2.84||$48,765.64|| |
|9/2/2016||Ryan J Morris||Director||Buy||4,600||$2.84||$13,064.00|| |
|11/19/2015||Eric K. Steen||CEO||Buy||2,461||$2.88||$7,087.68|| |
|11/12/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||29,600||$2.82||$83,472.00|| |
|11/3/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||7,689||$2.75||$21,144.75|| |
|10/28/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||17,100||$2.71||$46,341.00|| |
|10/13/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||14,290||$2.82||$40,297.80|| |
|10/12/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||1,860||$2.83||$5,263.80|| |
|8/24/2015||Eric K. Steen||CEO||Buy||5,000||$2.83||$14,150.00|| |
|8/19/2015||Eric K. Steen||CEO||Buy||7,360||$2.92||$21,491.20|| |
|8/18/2015||Jonathan P Foster||CFO||Buy||1,000||$2.92||$2,920.00|| |
|6/23/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||7,500||$3.19||$23,925.00|| |
|6/15/2015||Gregg Owen Lehman||Director||Buy||2,000||$3.23||$6,460.00|| |
|6/12/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||12,786||$3.16||$40,403.76|| |
|6/8/2015||Gregg Owen Lehman||Director||Buy||18,000||$3.19||$57,420.00|| |
|6/4/2015||David C Dreyer||Director||Sell||10,000||$3.15||$31,500.00|| |
|6/4/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||19,550||$3.15||$61,582.50|| |
|5/19/2015||Eric K Steen||CEO||Buy||5,682||$3.08||$17,500.56|| |
|5/15/2015||Jonathan P Foster||CFO||Buy||4,270||$3.07||$13,108.90|| |
|12/16/2014||Eric K Steen||CEO||Buy||15,100||$2.73||$41,223.00|| |
|12/4/2014||Eric K Steen||CEO||Buy||3,669||$2.65||$9,722.85|| |
|11/26/2014||Eric K Steen||CEO||Buy||10,000||$2.75||$27,500.00|| |
|11/17/2014||Eric K Steen||CEO||Buy||10,000||$2.69||$26,900.00|| |
|8/27/2014||Eric K Steen||CEO||Buy||15,000||$2.75||$41,250.00|| |
|8/18/2014||Eric K Steen||CEO||Buy||12,750||$2.79||$35,572.50|| |
|8/13/2014||Eric K Steen||CEO||Buy||7,262||$2.79||$20,260.98|| |
|8/11/2014||Eric K Steen||CEO||Buy||11,172||$2.71||$30,276.12|| |
|5/7/2014||Eric K Steen||CEO||Buy||10,000||$2.80||$28,000.00|| |
|3/17/2014||Ryan J Morris||Chairman||Sell||24,600||$2.90||$71,340.00|| |
|3/13/2014||Jonathan P Foster||CFO||Buy||5,000||$2.78||$13,900.00|| |
|8/14/2013||Eric K Steen||CEO||Buy||15,000||$1.42||$21,300.00|| |
InfuSystem (NYSEAMERICAN INFU) News Headlines
InfuSystem (NYSEAMERICAN:INFU) SEC Filings
|BlueLine Capital Partners II, L.P. (Reporting)|
BlueLine Partners, L.L.C. (Reporting)
Meridian OHC Partners, LP (Reporting)
Meridian TSV II, LP (Reporting)
TSV Investment Partners, LLC (Reporting)
Statement of changes in beneficial ownership of securities
Sansone Christopher R. (Reporting)
Statement of changes in beneficial ownership of securities
InfuSystem (NYSEAMERICAN:INFU) Income Statement, Balance Sheet and Cash Flow Statement
InfuSystem (NYSEAMERICAN INFU) Stock Chart for Monday, December, 11, 2017